Staying Informed

Ariad cancels trial of leukemia drug - Boston Globe


Boston Herald

Ariad cancels trial of leukemia drug
Boston Globe
By ending the late-stage trial of Iclusig, Ariadessentially abandoned a plan that had been considered key to its future: turning the pill — already on sale in the United States and Europe for use by patients whose cancers resist other treatments ...
pSivida Receives CRL from FDA for ILUVIEN; ARIAD Reports Discontinuation of ...HispanicBusiness.com

all 55 news articles »

 

This post is a mere snippet of world-wide industry news, sponsored by:
BizLocal.com
BizLocal is a web-property of Inspetta LLC, providing innovative web, software and marketing services to business.  Call 800-785-2925 for more information.

Comments
Only registered users can leave comments.
Comment text: